| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Mr. Yiping Ma CEO | XSHE Exchange | CNE100001YX5 ISIN |
| China Country | 1,937 Employees | 17 Jun 2026 Last Dividend | 12 Oct 2018 Last Split | - IPO Date |
Sichuan Goldstone Asia Pharmaceutical Inc. is a versatile enterprise based in Chengdu, China. Founded in 2001, the company is dedicated to the research, development, and sale of medicines and health products within the Chinese market. Beyond its biomedical ventures, Sichuan Goldstone Asia Pharmaceutical Inc. has diversified its portfolio to include the production and sale of an array of industrial goods, such as plastic composite pipes and various types of equipment and machinery. The company not only engages in manufacturing but also in the installation and maintenance of special equipment, alongside conducting import and export activities for a variety of spare parts, as well as raw and auxiliary materials.
The company is engaged in the research, development, and sale of various medicines and health-related products, focusing on meeting the healthcare needs of the Chinese market.
Sichuan Goldstone Asia Pharmaceutical Inc. produces high-quality plastic composite pipes and pipe fittings, catering to diverse industrial and construction requirements.
The enterprise develops and markets a wide range of industrial machinery, including vacuum coating equipment, aimed at serving various sectors such as construction and manufacturing.
It specializes in creating precision molds for pipe fittings and provides construction equipment, showcasing its capability in supporting construction and industrial activities.
The company not only produces but also installs and maintains special equipment tailored for specific industry needs, ensuring operational efficiency and reliability.
Engaging in the import and export of spare parts, along with raw and auxiliary materials, Sichuan Goldstone Asia Pharmaceutical Inc. supports the global supply chain with its comprehensive trade services.